InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Friday, 11/17/2017 3:05:41 PM

Friday, November 17, 2017 3:05:41 PM

Post# of 8491
"A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma



This study is currently recruiting participants.
See Contacts and Locations

Verified November 2017 by Janssen Research & Development, LLC

Sponsor:

Janssen Research & Development, LLC


ClinicalTrials.gov Identifier:

NCT03301220

First Posted: October 4, 2017

Last Update Posted: November 16, 2017"


Second Phase III Dara sc now recruiting.


Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News